Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. prepare

PREPARE SIGNED

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 PREPARE project word cloud

Explore the words cloud of the PREPARE project. It provides you a very rough idea of what is the project "PREPARE" about.

medical    million    allyn    capture    grow    marked    artifact    first    500    breathing    intensive    trl7    clinical    compromise    197    16    sales    distributor    hospitals    mindray    patient    ge    investigations    annual    2019    solutions    event    pmd    25    distributors    unplanned    5    60m    optimisation    postoperative    team    accurate    business    107    care    reject    rr    irish    generation    31bn    multinational    countries    globally    save    rc    settings    platform    negotiations    respirasense    intervention    vp    premier    welch    incidence    stay    rate    2020    ward    70    adoption    7    775m    10    opportunity    world    memorandum    admissions    sustain    21    differentiated    30    mortality    intermediate    length    total    4    ce    population    continents    mou    asian    asia    120    validated    liabilities    marketing    companies    gt    prospects    monitor    market    continuous    20    undertaking    400    respiratory    patients    hospital    america    monitoring   

Project "PREPARE" data sheet

The following table provides information about the project.

Coordinator		 PMD DEVICE SOLUTIONS LIMITED 

Organization address
address: BISHOPSTOWN HOUSE MODEL FARM ROAD
city: CORK
postcode: T12T922
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://www.pmd-solutions.com/
 Total cost 4˙265˙610 €
 EC max contribution 4˙265˙610 € (100%)
 Programme 1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2015
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PMD DEVICE SOLUTIONS LIMITED IE (CORK) coordinator 4˙265˙610.00

Map

 Project objective

The incidence rate of Respiratory Compromise (RC) in hospital settings is 7% in intermediate/general care ward patients (107 million patients) and 30% in step-down postoperative patients (197 Million patients), at an average cost of €16,500 per event. It will cost the EU €31Bn by 2019. PMD’s technology will lead to a 20% reduction in the average patient length of stay, a 10% reduction in unplanned intensive care admissions, and a 5% reduction in liabilities from patient mortality by enabling early intervention of Respiratory Compromise (RC). This will be achieved by enabling the continuous and accurate monitoring of general ward patients respiratory rate (70% of the total patient population). The business opportunity is PMD Solutions (PMD), with its unique respiratory monitoring platform technology and its premier TRL7 CE marked product RespiraSense - the world’s first continuous respiratory rate monitor that is highly differentiated due to its ability to reject non-breathing artifact. This proposal, through the undertaking of clinical investigations, product optimisation, new product development and sales and marketing, will enable PMD to capture 0.4% of the market and sustain a 400% annual growth rate by 2020. It will lead to the generation of >€60M with sales across 3 continents including Europe, America and Asia and to grow the team from 10 to 21 within 3 years. PMD currently has 1 agreement with an Irish distributor and 7 Memorandum of Understanding (MoU) with other distributors across Europe with a further 25 other prospects. PMD is also in negotiations with the VP of marketing at each of the top 2 US (Welch Allyn, GE Medical) and the top Asian (Mindray) multinational patient monitoring companies. Globally hospital’s will save €775M over the next 3 years through their adoption of continuous monitoring of respiratory rate (RR). The unique technology platform has been validated on over 120 patients across 5 clinical areas in 5 hospitals, across 5 countries.

 Deliverables

List of deliverables.
PR collateral Websites, patent fillings, videos etc. 2019-05-31 16:50:40

Take a look to the deliverables list in detail:  detailed list of PREPARE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREPARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREPARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.;H2020-EU.2.3.1.)

PREPARE (2016)

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Read More  

ADVANTAGE (2015)

ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach

Read More  

LASER-HISTO (2016)

In vivo histology using femtosecond laser multiphoton tomograph for the early diagnosis of skin cancer and corneal diseases while simultaneously reducing Europe’s health care costs

Read More